Live Longer. Live Better. Backed by Science.
Evidence-based longevity, biohacking, digital health, and nutrition — translated into clear, trustworthy guidance you can actually use.
Latest Articles
- Navigating GLP-1 Therapy: Why Consistent Use is Key for Lasting Benefits
New insights reveal frequent stop-and-start patterns in GLP-1 drug use. Learn why consistent adherence is crucial for optimal health outcomes. - Misplaced DNA: Unraveling Its Role in Chronic Inflammation and Thrombosis
New research reveals how mislocalized DNA and RNA fragments trigger chronic inflammation and a prothrombotic state, known as ‘coagul-aging,’ in older adults. - GLP-1 Medications and Movement: Unpacking the Activity Paradox
New data suggests individuals on GLP-1 weight loss drugs may see reduced physical activity. Vitalheros explores the implications for muscle health and longevity. - The Vital Role of Grandparents in Children’s Mental Well-being
Discover how grandparents offer crucial emotional support, stability, and wisdom, significantly contributing to children’s mental health in today’s complex world. - Gene Editing Breakthrough: In Vivo CRISPR Therapy for HAE Completes Phase 3
A landmark Phase 3 study for an in vivo CRISPR therapy targeting hereditary angioedema has successfully concluded, offering new hope for this debilitating genetic condition. - New DNA Test Offers Hope for Rare Genetic Disorder Diagnosis
A novel DNA test is revolutionizing the diagnosis of rare genetic disorders, promising faster answers and better treatment pathways for patients. - Unlocking Cellular Secrets: A New Frontier in Cancer Treatment
A deeper understanding of cellular processes could pave the way for innovative, more targeted cancer therapies, offering new hope in the fight against disease. - New Leadership Ignites Cell and Gene Therapy Research at Houston Methodist
Houston Methodist appoints a renowned physician-scientist to spearhead its cell and gene therapy research, signaling a major push in precision medicine. - FDA Approves New Adjuvant Therapy for High-Risk Kidney Cancer Patients
A new adjuvant treatment for clear cell renal cell carcinoma (ccRCC) recently received FDA approval, offering hope for patients at high risk of recurrence.
Browse by Topic
- Digital Health (73)
- Longevity & Biohacking (13)
- Nutrition & Performance (2)
- Uncategorized (41)